Nama, S., Muhuri, M., Di Pascale, F., Quah, S., Aswad, L., Fullwood, M., . . . Sciences, S. o. B. (2020). MicroRNA-138 is a prognostic biomarker for triple-negative breast cancer and promotes tumorigenesis via TUSC2 repression.
استشهاد بنمط شيكاغوNama, Srikanth, Manish Muhuri, Federica Di Pascale, Shan Quah, Luay Aswad, Melissa Fullwood, Prabha Sampath, و School of Biological Sciences. MicroRNA-138 Is a Prognostic Biomarker for Triple-negative Breast Cancer and Promotes Tumorigenesis Via TUSC2 Repression. 2020.
MLA استشهادNama, Srikanth, et al. MicroRNA-138 Is a Prognostic Biomarker for Triple-negative Breast Cancer and Promotes Tumorigenesis Via TUSC2 Repression. 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.